L-Q et al. Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched study. Eur J Cardiothorac Surg 2017;52:958-62. Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched study Abstract OBJECTIVES: The pattern of lymph node metastasis is a predominant element in tumour biology, which is closely related to optimal therapeutic modality. Controversy remains as to which histopathology type of oesophageal cancer-adenocarcinoma or squamous cell carcinoma (SCC)-is more likely to have lymph node metastasis. Therefore, this study aimed to apply propensity score-matched analysis to draw an objective conclusion for providing initial evidence of the potential need for different therapeutic strategies for these 2 cancer types.
INTRODUCTION
Oesophageal cancer is the eighth most common malignant tumour and the sixth most common cause of death from cancer worldwide [1] ; in terms of histopathology, it mainly consists of squamous cell carcinoma (SCC) and adenocarcinoma. In China, nearly 90% of cases of oesophageal cancer were found to be SCC [2] , while in the West, adenocarcinoma, particularly in the distal oesophagus, has surpassed SCC to become the predominant pathological type [3] . Evidence has shown that oesophageal SCCs and adenocarcinomas are totally different tumour entities with different molecular features [4] , pathogenesis and tumour biology mainly including patterns of lymph node metastasis and prognosis [5] . Given that lymph node metastasis remains to be an important determinant of poor prognosis for oesophageal cancer, as well as the fact that oesophageal adenocarcinomas and SCCs are now being treated as the same tumorous entity, it is necessary to study the different tendencies of lymph node metastasis in these 2 predominant pathological types of oesophageal cancer. Even though several studies have been carried out, their conclusions are far from consistent. Some have reported that patients with an oesophageal SCC had a higher risk of lymph node metastasis than did those with an adenocarcinoma [6] [7] [8] [9] . †The first three authors contributed equally to this study.
However, on the contrary, Alexiou et al. [10] reported that oesophageal SCC was less likely to have lymph node metastasis, and Rice et al. [11] also demonstrated that lymph node metastasis was more likely in patients with an oesophageal adenocarcinoma than in those with an SCC. Other studies even showed no difference in the lymph node metastasis rate between patients with an oesophageal SCC and those with an adenocarcinoma [12] [13] [14] . Given that the tendency for lymph node metastasis in oesophageal cancers is closely correlated with tumour location, T stage and lymphovascular invasion as well as the grade of differentiation [15, 16] , we believe that these controversial conclusions resulted from the unbalanced above-mentioned confounding factors. Therefore, to draw a reliable conclusion regarding the different tendency of lymph node metastasis between adenocarcinomas and SCCs, we tried to use a propensity score-matched (PSM) method, which is widely applied in analysing causal inference in observational studies by balancing confounding factors between groups and thus reducing bias [17] . We used this method to compare the rates of lymph node metastasis in patients with an oesophageal SCC and those with an adenocarcinoma, with the aim of providing initial evidence to justify offering different therapeutic strategies for these 2 types of tumour. To our knowledge, this is the first study applying PSM analysis to investigate this topic.
METHODS
We retrospectively reviewed and collected the data from patients who underwent surgery for oesophageal cancer in our department from January 2012 to June 2016. The inclusion criteria were (i) pathologically and immunohistochemically confirmed oesophageal SCC or adenocarcinoma, (ii) resectable oesophageal cancers (cT1-3, without enlarged lymph nodes or with enlarged lymph nodes but with no computed tomography-identified extracapsular lymph node invasion) and (iii) radical oesophagectomy with lymphadenectomy. The exclusion criteria were (i) preoperative neoadjuvant therapy, (ii) mixed cases of oesophageal SCC and adenocarcinoma and (iii) distant visceral metastasis. Our study was approved by the Ethics Committee of West China Hospital, Sichuan University (no. 20161011). Because our study was a retrospective study and analysed anonymously, the Committee waived the need for consent.
All included patients were grouped according to their histopathology (adenocarcinoma or SCC groups). The clinical characteristics for analysis included age, gender, body mass index (BMI), pathological findings, procedures used for oesophagectomy and rate of lymph node metastasis. The pathologic findings consisted of tumour grade, degree of lymphovascular invasion, numbers of lymph nodes dissected, numbers of positive lymph nodes, pT stage and tumour location. Tumour location was categorized into 4 parts: cervical/upper (15-25 cm from the incisor teeth), middle (25-30 cm), lower (30-40 cm) segments of the oesophagus and oesophagogastric junction according to the seventh edition of the American Joint Committee on Cancer staging system for cancers of the oesophagus and oesophagogastric junction [18] .
Statistical analysis
Statistical analysis was performed using IBM SPSS software (version 22.0; IBM Corp., Armonk, NY, USA). Data are represented as the mean ± standard deviation for continuous variables or number and (%) for categorical data. Independent-sample Student's t-test or the Mann-Whitney non-parametric U-test was applied for comparing continuously distributed data between groups, and v 2 test or Fisher's exact test was applied to categorical data between groups. PSM analysis was performed using R-2.15.1-win and PSMATCHING 3.04 software. The propensity scores were calculated from a logistic regression model with covariates including age, gender, BMI, procedure of oesophagectomy used, tumour grade, lymphovascular invasion, numbers of lymph node dissected, pT stage and tumour location. Selected cases from the 2 groups were matched at a ratio of 1:1 using the nearest-neighbour method with a caliper width of 0.02. A 2-sided P-value of <0.05 was considered statistically significant.
RESULTS

Comparison of lymph node metastasis between the unmatched groups
A total of 1204 patients (including 118 with an adenocarcinoma and 1086 with an SCC) were included for analysis. The clinical characteristics for comparison of the unmatched patients are presented in Table 1 . The mean age of patients with an adenocarcinoma was 61.0 ± 7.0 years with a male/female ratio of 4.6:1, while it was 60.1 ± 8.0 years with a male/female ratio of 4.6:1 in those with an SCC. The mean BMI values for the adenocarcinoma and SCC groups were 21.8 ± 3.3 and 21.5 ± 2.9 kg/m 2 , respectively. There were no significant differences between the 2 groups regarding age (P = 0.25), gender (P = 0.97) and BMI (P = 0.24). Because of surgeons' habit of choosing left thoracotomy as a predominant approach for treating oesophageal cancer in China, most patients in both groups underwent oesophagectomy and 2-field lymphadenectomy through a left thoracotomy (80.5% in the adenocarcinoma and 85.4% in the SCC groups), and the surgical procedures differed significantly between the unmatched groups (P < 0.001). In terms of pathology, most adenocarcinomas were located in the oesophagogastric junction (76.3%), while most cases of SCC were at the middle segment of the oesophagus (61.0%), and there was a significant difference in tumour location between the unmatched adenocarcinoma and SCC groups (P < 0.001). More than half of the cases of adenocarcinoma (56.8%) and SCC (54.0%) were found to be poorly differentiated (Grade 3), and no significant differences in grade were observed between the 2 groups (P = 0.73). However, the pT stage of cases of adenocarcinoma was significantly higher than that of cases of SCC (P = 0.011), and the rate of lymphovascular invasion in the former group was significantly higher (11.0% and 4.9%, respectively; P = 0.004) between the unmatched groups. The mean number of dissected lymph nodes in cases of adenocarcinoma tended to be lower than that of the SCC group (17.3 and 18.8, respectively; P = 0.080). However, the mean number of positive lymph nodes in cases of adenocarcinoma was significantly larger than that in cases of SCC (3.8 and 1.5, respectively; P < 0.001). Moreover, the rate of lymph node metastasis in cases of adenocarcinoma was significantly higher than that in cases of SCC (71.2% and 49.0%, respectively; P < 0.001).
Comparison of lymph node metastasis rates between the matched groups
To investigate the actual difference in lymph node metastasis between the 2 groups, PSM analysis was applied by matching the following covariates: gender, age, BMI, surgery, tumour grade, degree of lymphovascular invasion, numbers of lymph node dissected, pT stage and tumour location. A total of 48 pairs were matched, and the clinical characteristics of those matched patients are shown in Table 2 . All these covariates for matching including age (P = 0.53), gender (P = 1.00), BMI (P = 0.92), procedure of oesophagectomy (P = 0.65), tumour location (P = 0.94), tumour grade (P = 0.60), pT stage (P = 0.93), degree of lymphovascular invasion (P = 0.75) and mean numbers of lymph node dissected (P = 0.42) were well matched. However, there were still significant differences in the mean numbers of positive lymph nodes and the rates of lymph node metastasis. Adenocarcinoma cases showed significantly more mean numbers of positive lymph nodes (4.5 and 1.8, respectively; P = 0.003) and higher rates of lymph node metastasis (75.0% and 45.8%, respectively; P = 0.003) than in the SCC cases.
DISCUSSION
The lymphatic drainage of the oesophagus runs longitudinally and transversally [8] ; therefore, the patterns of lymph node metastasis of oesophageal cancers are complex and widespread [5] . Even though efforts have been made to compare the patterns of lymph node metastasis between cases of oesophageal adenocarcinoma and SCC, there is still controversy. Some studies concluded that oesophageal SCC is more aggressive in terms of lymph node metastasis than in adenocarcinoma [6] [7] [8] [9] , while other studies drew the opposite conclusion that cases of adenocarcinoma are more likely to have lymph node metastases than cases of SCC [10, 11] .
Here, we tried to reach an objective conclusion about comparing the rates of lymph node metastasis between cases of adenocarcinoma and SCC. At first, in the analysis of the unmatched patients, we found that the mean numbers of positive lymph nodes in those with an adenocarcinoma were significantly more than in the SCC group (P < 0.001) and the rate of lymph node metastasis was also significantly higher (P < 0.001). However, this result might have been biased, because it was based on unmatched patients and there were many confounding factors, such as surgical procedures, tumour location, pT stage, lymphovascular invasion, which had not been balanced. This might be why previous studies have drawn controversial conclusions about the same topic, as nearly all of them did not balance those confounding factors between groups when making comparisons [6] [7] [8] [9] [10] [12] [13] [14] . Therefore, we applied PSM analysis to generate wellmatched patient pairs by balancing those confounding factors to eliminate the bias. In this analysis of matched pairs of patients, whose baseline data were well matched, we still found that cases of adenocarcinoma had significantly larger mean numbers of positive lymph nodes (P = 0.003) and a higher rate of lymph node metastasis (P = 0.003) than cases of SCC. Taken together, we believe that cases of oesophageal adenocarcinoma are more likely to have lymph node metastases than cases of oesophageal SCC. To our knowledge, this is the first study to draw a relatively objective conclusion by applying PSM analysis. Oesophageal adenocarcinoma and SCC are 2 different entities with different pathogenesis, epidemiology, tumour biology and prognosis [7] . In the upcoming eighth edition of the staging primer for cancers of the oesophagus and oesophagogastric junction, adenocarcinoma was staged higher than SCC even when they were at the same pT, pN and M stages (e.g. for the same lower segment oesophageal cancer with T3N0M0 Grade 2, adenocarcinoma was staged as IIB, while SCC was staged as IIA), indicating different biological behaviours of these 2 tumour types [19] . Although it is believed that cases of oesophageal adenocarcinoma had a lesser degree and prevalence of lymphatic vessel invasion than cases of SCC, which could contribute to the better prognosis of the former [20] , recent studies have showed that cases of adenocarcinoma had a higher rate of occult lymph node metastasis than cases of SCC (31% vs 17%) [21] , and the rate of lymph node metastasis in cases of adenocarcinoma was significantly higher than in those with SCC (65% vs 55%, P = 0.028) [10] . Khan et al. [22] have found that even in patients with nodenegative oesophageal cancers, those with an adenocarcinoma had significantly poorer outcome than did those with an SCC. Alexiou et al. [10] have also demonstrated that oesophageal SCCs were less aggressive than adenocarcinomas. Our current study adds more to the evidence supporting that cases of oesophageal adenocarcinoma are more likely to have lymph node metastasis and therefore are more aggressive than cases of SCC. In terms of clinical implications, different therapeutic strategies are indicated for oesophageal adenocarcinomas in the future. For example, more extensive lymphadenectomy might be needed for accurate pN staging of adenocarcinomas, and because of the more malignant behaviour of adenocarcinomas, neoadjuvant and adjuvant therapy might be more emphasized for oesophageal adenocarcinomas.
Limitations
Even though our study yielded objective results through PSM analysis, there were still several limitations. First, because of the rarity of adenocarcinomas in Chinese patients, a relatively small sample size of the matched patients could decrease our analytical power. Second, we conducted this study only based on Chinese patients, but whether similar phenomena could be observed in Western patients need further study because the types of adenocarcinoma might differ between these ethnic groups [23] . Therefore, more studies are needed to confirm and update our conclusions.
CONCLUSIONS
Here, we compared the patterns of lymph node metastasis in cases of oesophageal adenocarcinoma and SCC through PSM analysis. Cases of adenocarcinoma were found to be more likely to have lymph node metastasis than cases of SCC, indicating the need for different therapeutic modalities for these 2 different tumour types. For example, more extensive lymphadenectomy and intensive adjuvant chemoradiotherapy should be emphasized for cases of oesophageal adenocarcinoma. However, further studies are needed to validate and update our conclusions. 
